Discovery of new treatment for pancreatic cancer

As reported by the BBC, Cancer Research funded scientists have identified a previously unknown faulty gene that appears to play a key role in some aggressive forms of pancreatic cancer.

A study published in the journal Nature, showed that a gene was being switched off in the cancerous cells. Scientists from Cancer Research UK’s Cambridge Research Institute and the Wellcome Trust Sanger Institute said drugs were already being tested which had the potential to turn the gene back on, to stop the spread of the cancer.

Currently around 8000 people in the UK are diagnosed with pancreatic cancer every year and fewer than one in five patients survive their disease for a year or more

Dr Julie Sharp, Cancer Research UK’s senior science information manager, said: “These results raise the possibility that a class of promising new cancer drugs may be effective at treating some pancreatic cancers.”

Click here to see our latest clinical roles

Follow us on Twitter @CKClinical to receive more industry news and CK jobs of the week updates

Posted in: Industry News, News
CK Logo in place of featured image